Article
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis
2025-03-01
Abstract excerpt
Metabolic dysfunction-associated steatohepatitis (MASH) represents a progressive form of steatotic liver disease which increases the risk for fibrosis and advanced liver disease. The accumulation of discrete species of bioactive lipids has been postulated to activate signaling pathways that promote inflammation and fibrosis. However, the key pathogenic lipid species is a matter of debate. We explored candidates us...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6d0b1199-1190-562e-9b95-79082ce54ec5
- DOI
- 10.1101/2025.02.25.640203
